|Articles|May 18, 2022

M3 Wake Research Acquires Multi-specialty Research Associates

Addition of clinical research site expands operations into Florida.

M3 Wake Research announces the acquisition of Multi-specialty Research Associates (MSRA) in Lake City, Florida. This acquisition expands Wake Research's coverage of clinical research populations in the United States and encompasses communities at 23 locations across eight states.

Read more about the acquisition here.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Articles

Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025
Trial Data Leads to NCCN Recommendation for Modeyso in Recurrent High Grade Glioma Patients
September 12th 2025
Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV Patients
September 12th 2025
Latest NIMBLE Study Results Highlight Progress in gMG Research
September 12th 2025
FDA Fast Tracks Sanofi’s Intravitreal Gene Therapy for Neovascular Age-Related Macular Degeneration
September 11th 2025
ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug Trials
September 11th 2025

Trending on Applied Clinical Trials Online

Latest NIMBLE Study Results Highlight Progress in gMG Research

Trial Data Leads to NCCN Recommendation for Modeyso in Recurrent High Grade Glioma Patients

Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV Patients

Q&A: Strategies for Successful Global Clinical Trial Delivery

© 2025 MJH Life Sciences^®

All rights reserved.